Agent: Beverly Slopen, Beverly Slopen Literary Agency (Canada). Publication date 2012 Topics Drug Industry, Drug Utilization Publisher Berkeley : University of California Press. Still, Healy’s contrarian streak and sharpness make this a disturbing, well-documented indictment that echoes many others in recent years, and one worth heeding. David Healy Pharmageddon 302pp - 19.95 ISBN 978-0520275768 Berkeley: University of California Press, 2012 The tale of the big bad pharmaceutical industry. But he seems contrarian in opposing chronic disease management because it provides drug companies the opportunity for long-term sales of drugs that manage, but do not cure, a condition. David Healy’s most comprehensive and forceful argument against the pharmaceuticalization of medicine, tackles problems in health care that are leading to a growing number of deaths and disabilities.

David Healy: Bad Medicine - Lecture 2 - Pharmageddon: Cardiff University psychiatrist Dr. He is particularly incisive on how the drug industry distorts medical care by, say, encouraging the use of statins like Lipitor rather than advising patients to lose weight. View 2035 Videos + Podcasts.pdf from SOWK 2035 at York University. He takes particular aim at the outsourcing to private companies of clinical drug trials, once the domain of the National Institutes of Health and academics and now a $30 billion industry.

Healy chronicles the rise of blockbuster drugs like Prozac and Vioxx and how drug companies hyped them while downplaying their hazards. “We are quite literally taking drugs to save the lives of companies who have a greater interest in the vitality of the diseases they market drugs for than in our well-being,” argues British psychiatrist Healy (Let Them Eat Prozac) in this scathing critique of the $900 billion global pharmaceutical industry.

Pharmageddon by david healy